License U of T Technologies

Who is this for?

Industry and other parties interested in licensing or otherwise using University of Toronto (U of T) technologies or working with spinoff companies based on U of T intellectual property.

What do I need before I can begin?

No information is required to begin. If you have questions regarding licensing University of Toronto (U of T) technologies or working with our spinoff companies, please reach out to the Innovations & Partnerships Office: Director, Innovations at 416-946-5515.

Technology Licensing & Startup Opportunities

The University of Toronto (U of T) is a global leader in turning research into products, services, companies and jobs. The Innovations & Partnerships Office (IPO) is your one-stop-shop to license these technologies or work with spinoff companies based on U of T intellectual property (IP). IPO’s team of technology transfer professionals make the process as quick and easy as possible.

Use the Technology Explorer below to discover market-ready innovations and companies based on U of T IP or contact us to find custom solutions.

Deep Tech Download Newsletter

For the latest on active investment opportunities and developments at companies emerging from U of T Research, sign up for the Deep Tech Download newsletter. With more than $1.5 billion raised by research-based companies in the last 5 years, Deep Tech Download is your inside track to get involved!

Technology Explorer

Technology Keywords
Nanoconstructs for Diagnosis and Treatment of Alzheimer’s Disease Alzheimer's disease , Neurological Disorders , Dementia , Therapeutics , Diagnostics , Theranostic , Nanoparticle , Biomedical Imaging , MRI , Biomarkers , Amyloid plaque , Brain 
Genetically Engineered Proteins for Diagnosis and Treatment of Crohn’s Disease Crohn's disease , IBD , Inflammatory bowel disease , cytokine , Therapeutics , Diagnostics , Intestine , Immunology 
The Glucose Meter as a Detection System for Point-of-Care Gene Circuit Diagnostics Point-of-Care , Covid-19 , Diagnostics , Molecular Detection , Synthetic Biology , SARS-COV-2 , Cell Free , Protein Syntheis , Glucose Meter , PCR , Typhoid , Covid-19 , Reporter Gene , Virus , Bacteria , Ag Tech , Agriculture , Food Safety , Animal Health 
Assay for Rapid and Sensitive Detection of SARS-CoV-2 Antibodies Covid-19 , SARS-COV-2 , Immunoassay , Diagnostics , Clinical Tests , Virus 
Immunotyping COVID-19 Patients Using Novel Protein Complementation-Based Assay Covid-19 , Diagnostics , Protein-Protein Interactions , Infectious Diseases , Clinical Tests , Pandemic , Immunoassay , SARS-COV-2 , Virus , Antibodies 
Re-PAIR: A CRISPR-Based Technology for Portable Diagnostics & Biotechnology CRISPR , Portable  , Diagnostics , Biotechnology , Biosensor , Cell-Free System , Nucleic Acid 
SanoMetrics: AI-powered sleep disease classification and health metrics from wearables Advanced Health Technologies , Artificial Intelligence (AI) , Deep Learning , Data Analytics , Research Tools , Diagnostics , Software , Wearable Tech , Remote monitoring 
Implantable Systems for Monitoring, Diagnosis, and Control of Physiological Disorders Artificial Intelligence (AI) , Chips , Computer Hardware , Diagnostics , Electrical and Computer Engineering , Machine Learning , Medical Devices , Medical Implants and Prosthetics , Microelectrodes , Nanotechnology , Neurological Disorders , Seizures 
MNAzyme-Based Gold Nanoparticle Sensor Cancer , Diagnostics , Disease Detection , Medical Devices , Nanomaterials and Nanoparticles , Patient Care , Point-of-Care , Sensors & Instrumentation 
Multiplexed Genetic Detection with Isothermal Signal Amplification Cancer , Chips , Diagnostics , Disease Detection , Genetics , Infectious Diseases , Nanomaterials and Nanoparticles , Point-of-Care , Polymers , Quantum Dots , Smartphones 

VPRI Role

  • Market U of T technologies to industry
  • Support the development of startup companies
  • Negotiate license agreements with interested companies
  • Assist in finding partners and funding to support proof-of-concept and commercialization
  • Support long-term relationships with strategic partners that help develop early-stage discoveries into market-ready technologies and products

VPRI Contact

Staff

Jennifer Fraser

Director, Innovations
Innovations & Partnerships Office (IPO)
(416) 946-5515